Oral [spco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
Increase [ftcn]
Plasma [bdsu]
von Willebrand Factor [aapp, bacs, phsu]
postmenopausal [tmco]
Women [popg]
objectives [inpr]
To [qlco]
Test [lbpr]
One [qnco]
month [tmco]
Daily [tmco]
Oral [spco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
Transdermal [ftcn]
Estradiol [horm, phsu, strd]
Altered [ftcn]
haemostatic [ortf]
Factor [ftcn]
postmenopausal [tmco]
Subject [grup]
Background [cnce]
Estrogen Replacement Therapy [topp]
therapy, hormonal [topp]
Replacement [topp]
Effect [qlco]
Early [tmco]
Increase [ftcn]
cardiovascular events [fndg]
postmenopausal [tmco]
Women [popg]
Circulating [ftcn]
Plasma [bdsu]
von Willebrand factor antigen [aapp, bacs, phsu]
Marker [clna]
Generalized [spco]
endothelial dysfunction [dsyn]
Methods [inpr]
Eight [qnco]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Average [qnco]
randomized [resa]
To [qlco]
Receive [qlco]
Daily [tmco]
Oral [spco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
mg% [qnco]
N NOS [aapp, imft]
Transdermal [ftcn]
Estradiol [horm, phsu, strd]
mg day [qnco]
N NOS [aapp, imft]
Oral [spco]
placebo [topp]
N NOS [aapp, imft]
One [qnco]
month [tmco]
blood samples [bdsu]
Collected [idcn]
baseline [bodm]
Two [qnco]
weeks [tmco]
Four [qnco]
weeks [tmco]
therapy [ftcn]
Measurement [ftcn]
Circulating [ftcn]
Plasma [bdsu]
Hormones [horm]
Lipid [lipd]
Concentrations [menp]
haemostatic [ortf]
Factor [ftcn]
Result [ftcn]
Oral [spco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
Decreased [qnco]
Total Cholesterol [lbpr]
P NOS [aapp, imft]
Low Density Lipoprotein Cholesterol [bacs, strd]
P NOS [aapp, imft]
Increased [qnco]
Triglycerides [bacs, lipd]
P NOS [aapp, imft]
High Density Lipoprotein Cholesterol [bacs, lipd]
P NOS [aapp, imft]
Transdermal [ftcn]
Estradiol [horm, phsu, strd]
Effect [qlco]
Lipids [lipd]
Oral [spco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
Transdermal [ftcn]
Estradiol [horm, phsu, strd]
Users [humn]
Not [ftcn]
Statistical Significance [qnco]
Fibrin D-dimer [aapp, bacs]
Antigen [imft]
Not [ftcn]
Group [idcn]
Oral [spco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
Users [humn]
Increase [ftcn]
von Willebrand Factor [aapp, bacs, phsu]
baseline [bodm]
Four [qnco]
weeks [tmco]
P NOS [aapp, imft]
Decrease [qlco]
Tissue-Type Plasminogen Activator [aapp, enzy, phsu]
Antigen [imft]
baseline [bodm]
Four [qnco]
weeks [tmco]
P NOS [aapp, imft]
Different [qlco]
Change [ftcn]
Observed [ftcn]
Transdermal [ftcn]
Estradiol [horm, phsu, strd]
Group [idcn]
P NOS [aapp, imft]
Conclusions [idcn]
Data [idcn]
Suggest [idcn]
Oral [spco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
mediated [socb]
Increase [ftcn]
Plasma [bdsu]
von Willebrand Factor [aapp, bacs, phsu]
Clinical [qlco]
Relevance [qlco]
GIVEN [cnce]
Early [tmco]
effects [qlco]
therapy, hormonal [topp]
Replacement [topp]
postmenopausal [tmco]
Women [popg]
[c] [qnco]
American [popg]
College [mnob]
Cardiology [bmod]
Foundation [orgt]
